Beiersdorf Venture Capital — Pre-Seed & Growth VC Firm ($500K–$5.0M Checks)
Beiersdorf Venture Capital is a Pre-Seed, Growth venture capital firm investing in Healthcare, Climate / Energy, AI / ML. The firm typically writes $500K–$5.0M checks and has 17 portfolio companies in our records.
- Check size
- $500K–$5.0M
- Portfolio
- 17 companies on record
- Partners
- 1 listed
- Stage
- Pre-Seed, Growth
- Sectors
- Healthcare, Climate / Energy, AI / ML, Food / AgTech, Consumer
- AUM
- Not in our records
Last verified: 2026-10-26
Pre-Seed, Growth
$500K – $5.0M
17+ companies
1 partner
Investment Thesis
Beiersdorf’s venture arm invests at the intersection of life sciences, biotech, sustainability, and consumer technology, with a stated focus on the future of skin care. Its sweet spot includes early-stage investments relevant to novel skincare ingredients and enabling technologies.
How Beiersdorf Venture Capital invests
Beiersdorf Venture Capital is a vc firm. The firm invests at the Pre-Seed, Growth stages, with a focus on Healthcare, Climate / Energy, AI / ML, Food / AgTech, Consumer.
Beiersdorf Venture Capital typically writes checks of $500K–$5.0M per investment.
Beiersdorf Venture Capital has backed 17 companies in our records, including Cellvie, Evommune, Macro Biologics.
Partners & Team
Unknown
GP
Industry Focus
Invests In
Portfolio Companies (17)
Other
Cellvie
The US-based biotech company Cellvie focuses on therapeutic mitochondria transplantation, a novel treatment approach aimed at the cellular energy metabolism.
Evommune
The US-based life science company Evommune discovers and develops novel therapies to treat immune-mediated chronic inflammatory diseases.
Macro Biologics
The US-based life science company Macro Biologics develops large molecule biologics that can alleviate or improve skin issues and prevent wound infections.
Rubedo Life Sciences
The US-based life science startup Rubedo discovers and develops medicines to keep you biologically young by targeting the pathologic cells that drive aging.
Vincere Biosciences
The US-based life science company Vincere Biosciences develops molecules that inhibit USP30 (ubiquitin-specific protease 30), an enzyme that blocks the removal of damaged mitochondria.
S-Biomedic
Our Belgian partner S-Biomedic uses life science expertise for exploring the therapeutic and cosmetic advantages of the skin microbiome.
DeepLife
The France-based biotech company DeepLife uses AI and systems engineering to model diseased cells and identify molecular triggers for drug discovery.
Turbine
The UK-based biotech company Turbine uses AI-powered simulated cells to run virtual biological experiments and identify which drug hypotheses are most likely to translate to patients.
Dermanostic
The Germany-based start-up Dermanostic offers dermatological diagnoses via app, allowing for quick, simple, cost-effective, and professional advice for skin indications.
DePoly
The Swiss-based deep tech startup DePoly develops a recycling solution to turn plastics back into raw material without affecting quality.
- •Raising at Pre-Seed, Growth? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, Climate / Energy, AI / ML — the sectors they actively back.
- •Size your ask to their typical $500K – $5.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Unknown, GP.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Beiersdorf Venture Capital is a match for your startup
Upload your pitch deck to see how well you match with Beiersdorf Venture Capital and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal